109 related articles for article (PubMed ID: 22171791)
41. Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development.
Yu Y; Liu X; Yang Y; Zhao X; Xue J; Zhang W; Yang A
Oncol Lett; 2015 Jul; 10(1):392-398. PubMed ID: 26171037
[TBL] [Abstract][Full Text] [Related]
42. Effects of high-risk human papillomavirus infection on P53, pRb, and survivin in lung adenocarcinoma-a retrospective study.
Sun W; Yang H; Cao L; Wu R; Ding B; Liu X; Wang X; Zhang Q
PeerJ; 2023; 11():e15570. PubMed ID: 37520249
[TBL] [Abstract][Full Text] [Related]
43. Carcinoma of the lung in Okinawa, Japan: with special reference to squamous cell carcinoma and squamous metaplasia.
Nakazato I; Hirayasu T; Kamada Y; Tsuhako K; Iwamasa T
Pathol Int; 1997 Oct; 47(10):659-72. PubMed ID: 9361099
[TBL] [Abstract][Full Text] [Related]
44. The molecular fingerprint of human papillomavirus infection and its effect on the Langerhans cell population in squamous cell carcinomas of the genital skin.
Rios-Yuil JM; Herrera-Gonzalez NE; Aguilar-Faisal JL; Lara-Padilla E; Mercadillo-Perez P; Moreno-Lopez LM; Marquez-Ramirez AK; Saldana-Patino A; Rubio-Gayosso I
Indian J Dermatol Venereol Leprol; 2014; 80(4):381. PubMed ID: 25035383
[TBL] [Abstract][Full Text] [Related]
45. Association between p53 status, human papillomavirus infection, and overall survival in advanced oral cancer after resection and combination systemic treatment.
Cutilli T; Leocata P; Dolo V; Altobelli E
Br J Oral Maxillofac Surg; 2016 Feb; 54(2):198-202. PubMed ID: 26669794
[TBL] [Abstract][Full Text] [Related]
46. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients.
Park MS; Chang YS; Shin JH; Kim DJ; Chung KY; Shin DH; Moon JW; Kang SM; Hahn CH; Kim YS; Chang J; Kim SK; Kim SK
Yonsei Med J; 2007 Feb; 48(1):69-77. PubMed ID: 17326248
[TBL] [Abstract][Full Text] [Related]
47. HPV and lung cancer risk: a meta-analysis.
Zhai K; Ding J; Shi HZ
J Clin Virol; 2015 Feb; 63():84-90. PubMed ID: 25315992
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.
Iwakawa R; Kohno T; Enari M; Kiyono T; Yokota J
Cancer Sci; 2010 Aug; 101(8):1891-6. PubMed ID: 20557307
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of HPV integration in cervical adenocarcinoma and squamous carcinoma.
Bi Y; Hu J; Zeng L; Chen G; Cai H; Cao H; Ma Q; Wu X
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17973-17986. PubMed ID: 37966613
[TBL] [Abstract][Full Text] [Related]
50. Comparative Expression of Apoptotic Markers in Lung Adenocarcinoma and Squamous Cell Carcinoma.
Porębska I; Kosacka M; Sobańska E; Wyrodek E; Jankowska R
Adv Exp Med Biol; 2015; 873():101-7. PubMed ID: 26022894
[TBL] [Abstract][Full Text] [Related]
51. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
Huang Q; Li F; Ji M; Lin L; Hu C
BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
[TBL] [Abstract][Full Text] [Related]
52. Association between HPV 16/18 infection and expression of P53 protein in laryngeal papillomas.
Chu H; Reyt E
J Tongji Med Univ; 1999; 19(4):275-6. PubMed ID: 12938516
[TBL] [Abstract][Full Text] [Related]
53. Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.
Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Sun X
Oncotarget; 2017 May; 8(21):34507-34515. PubMed ID: 28427144
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical p53 expression patterns in sarcomatoid carcinomas of the upper respiratory tract.
Ansari-Lari MA; Hoque MO; Califano J; Westra WH
Am J Surg Pathol; 2002 Aug; 26(8):1024-31. PubMed ID: 12170089
[TBL] [Abstract][Full Text] [Related]
55. [HPV (Human Papilloma Virus) implication in other cancers than gynaecological].
Badoual C; Tartour E; Roussel H; Bats AS; Pavie J; Pernot S; Weiss L; Mohamed AS; Thariat J; Hoffmann C; Péré H
Rev Med Interne; 2015 Aug; 36(8):540-7. PubMed ID: 25661671
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.
Shiau MY; Fan LC; Yang SC; Tsao CH; Lee H; Cheng YW; Lai LC; Chang YH
PLoS One; 2013; 8(1):e54423. PubMed ID: 23349885
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical expression of apoptosis regulators in squamous cell carcinoma of the cervix and their association with human papillomavirus 16/18 subtypes.
Ayatollahi H; Sharifi N; Sadeghian MH; Alenabi A; Ghasemian-Moghadam HR
Balkan Med J; 2014 Sep; 31(3):202-7. PubMed ID: 25625017
[TBL] [Abstract][Full Text] [Related]
58. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis.
Xiong WM; Xu QP; Li X; Xiao RD; Cai L; He F
Oncotarget; 2017 Nov; 8(56):96419-96432. PubMed ID: 29221217
[TBL] [Abstract][Full Text] [Related]
59. The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue.
Rezaei M; Mostafaei S; Aghaei A; Hosseini N; Darabi H; Nouri M; Etemadi A; Neill AO; Nahand JS; Mirzaei H; Donnelly SC; Doroudian M; Moghoofei M
BMC Cancer; 2020 Sep; 20(1):916. PubMed ID: 32972386
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
